These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 19832990

  • 1. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.
    Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
    [Abstract] [Full Text] [Related]

  • 2. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
    Wang Y, Xie X, Zhang C, Su M, Gao S, Wang J, Lu C, Lin Q, Lin J, Matucci-Cerinic M, Furst DE, Zhang G.
    Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
    [Abstract] [Full Text] [Related]

  • 3. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT, Østergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, Jacobsen S, Heegaard NH.
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [Abstract] [Full Text] [Related]

  • 4. Identification of a Novel Serum Proteomic Signature for Primary Sjögren's Syndrome.
    Padern G, Duflos C, Ferreira R, Assou S, Guilpain P, Maria ATJ, Goulabchand R, Galea P, Jurtela M, Jorgensen C, Pers YM.
    Front Immunol; 2021 Apr; 12():631539. PubMed ID: 33708222
    [Abstract] [Full Text] [Related]

  • 5. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
    Arcani R, Bertin D, Bardin N, Mazodier K, Jean R, Suchon P, Venton G, Daumas A, Jean E, Villani P, Kaplanski G, Jarrot PA.
    Rheumatology (Oxford); 2021 Sep 01; 60(9):4074-4084. PubMed ID: 33404653
    [Abstract] [Full Text] [Related]

  • 6. Altered β2 -glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies.
    Mobarrez F, Gunnarsson I, Svenungsson E.
    J Thromb Haemost; 2017 Sep 01; 15(9):1799-1806. PubMed ID: 28667788
    [Abstract] [Full Text] [Related]

  • 7. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
    Fragoulis GE, Vakrakou AG, Papadopoulou A, Germenis A, Kanavakis E, Moutsopoulos HM, Manoussakis MN.
    J Autoimmun; 2015 Jan 01; 56():12-22. PubMed ID: 25228497
    [Abstract] [Full Text] [Related]

  • 8. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
    Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A.
    Singapore Med J; 2007 Sep 01; 48(9):847-9. PubMed ID: 17728967
    [Abstract] [Full Text] [Related]

  • 9. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D, DeClerck LS, Bridts CH, Stevens WJ.
    In Vivo; 1994 Sep 01; 8(4):577-80. PubMed ID: 7534494
    [Abstract] [Full Text] [Related]

  • 10. Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.
    Mobarrez F, Vikerfors A, Gustafsson JT, Gunnarsson I, Zickert A, Larsson A, Pisetsky DS, Wallén H, Svenungsson E.
    Sci Rep; 2016 Oct 25; 6():36025. PubMed ID: 27777414
    [Abstract] [Full Text] [Related]

  • 11. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
    Burbano C, Villar-Vesga J, Orejuela J, Muñoz C, Vanegas A, Vásquez G, Rojas M, Castaño D.
    Front Immunol; 2018 Oct 25; 9():322. PubMed ID: 29545790
    [Abstract] [Full Text] [Related]

  • 12. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity.
    Wang Y, Chen S, Chen J, Xie X, Gao S, Zhang C, Zhou S, Wang J, Mai R, Lin Q, Lin J, Matucci-Cerinic M, Zhang G, Furst DE.
    Ann Rheum Dis; 2020 Feb 25; 79(2):268-275. PubMed ID: 31848144
    [Abstract] [Full Text] [Related]

  • 13. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y, Su Y, He J, Yang Y, Shi Y, Cui Y, Luo C, Wu X, Liu X, Hu F, Ma X, Zheng L, Zhang J, Zuo X, Sheng Y, Wu L, Zhang X, Guo J, Li Z.
    Ann Rheum Dis; 2015 Nov 25; 74(11):2070-5. PubMed ID: 24906639
    [Abstract] [Full Text] [Related]

  • 14. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
    Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, Liu Y, Jiang J, Luo S, Tan Y, Wu H, Renauer P, Del Mar Ayala Gutiérrez M, Castillo Palma MJ, Ortega Castro R, Fernández-Roldán C, Raya E, Faria R, Carvalho C, Alarcón-Riquelme ME, Xiang Z, Chen J, Li F, Ling G, Zhao H, Liao X, Lin Y, Sawalha AH, Lu Q.
    Ann Rheum Dis; 2016 Nov 25; 75(11):1998-2006. PubMed ID: 26787370
    [Abstract] [Full Text] [Related]

  • 15. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.
    Ann Rheum Dis; 2007 Jun 25; 66(6):790-7. PubMed ID: 17185325
    [Abstract] [Full Text] [Related]

  • 16. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG.
    J Autoimmun; 2006 May 25; 26(3):165-71. PubMed ID: 16621447
    [Abstract] [Full Text] [Related]

  • 17. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
    López P, Rodríguez-Carrio J, Martínez-Zapico A, Caminal-Montero L, Suárez A.
    Int J Cardiol; 2017 Jun 01; 236():138-144. PubMed ID: 28279502
    [Abstract] [Full Text] [Related]

  • 18. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC, Chou PL, Cheng CW, Chang YS, Chi WM, Tsai KL, Chen WJ, Kung TS, Tai CC, Lee KW, Chen YC, Lin CY.
    J Proteomics; 2016 Jun 01; 141():1-11. PubMed ID: 27072115
    [Abstract] [Full Text] [Related]

  • 19. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
    Zhou Z, Xu A, Teng J, Wang F, Tan Y, Liu H, Cheng X, Su Y, Shi H, Hu Q, Chi H, Li J, Hou J, Sun Y, Yang C, Ye J.
    J Immunol Res; 2020 Jun 01; 2020():2180708. PubMed ID: 33224991
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
    Blokland SLM, van den Hoogen LL, Leijten EFA, Hartgring SAY, Fritsch R, Kruize AA, van Roon JAG, Radstake TRDJ.
    Rheumatology (Oxford); 2019 Oct 01; 58(10):1740-1745. PubMed ID: 31220315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.